buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 1...

FDA Recall #D-0590-2024 — Class II — June 24, 2024

Recall #D-0590-2024 Date: June 24, 2024 Classification: Class II Status: Ongoing

Product Description

buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.

Reason for Recall

Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

Recalling Firm

Amerisource Health Services LLC — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,484 cartons

Distribution

Nationwide in the USA

Code Information

Lot 1017343, Exp. 12/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated